| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.07B | -8.8% |
| Cost of Revenue | $2.09B | -11.4% |
| Gross Profit | $2.98B | -6.9% |
| R&D Expense | $1.15B | +0.5% |
| SG&A Expense | $245.8M | -3.8% |
| Operating Income | $291.8M | -37.9% |
| Pre-tax Income | $298.0M | -14.6% |
| Income Tax | $500K | -98.3% |
| Net Income | $287.9M | -7.2% |
| EPS (Basic) | $0.88 | -9.3% |
| EPS (Diluted) | $0.86 | -9.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.22B | +14.6% |
| Short-term Investments | $160.3M | +15.0% |
| Accounts Receivable | $1.16B | +11.4% |
| Inventory | $830.1M | -12.8% |
| Current Assets | $3.85B | +1.3% |
| Total Assets | $10.01B | +5.1% |
| Current Liabilities | $2.64B | +25.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $788.1M | -9.7% |
| Investing Cash Flow | -$390.3M | -477.4% |
| Financing Cash Flow | -$232.7M | +62.4% |
| Long-term Debt |
| $1.62B |
| -0.1% |
| Total Liabilities | $5.22B | +3.9% |
| Stockholders' Equity | $4.78B | +6.5% |